Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7755804 | 1.00 | CHRM1 (0.30) | CHRM1CHRM2PLA2G1BATG4B | |
| SCHEMBL7755810 | 1.00 | CHRM1 (0.30) | CHRM1CHRM2PLA2G1BATG4B | |
| SCHEMBL7755788 | 1.00 | CHRM1 (0.30) | CHRM1CHRM2PLA2G1BATG4B | |
| SCHEMBL7757731 | 1.00 | CHRM1 (0.30) | CHRM1CHRM2PLA2G1BATG4B | |
| SCHEMBL7753133 | 0.79 | — | — | |
| SCHEMBL7756563 | 0.79 | — | — | |
| SCHEMBL3686670 | 0.79 | — | — | |
| SCHEMBL7755779 | 0.79 | — | — | |
| SCHEMBL7757270 | 0.79 | — | — | |
| SCHEMBL313666 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0761664-B1 | Camphor derivatives as new odorants | GIVAUDAN SA (CH) | 2001-03-14 | — | — | EP | claimed |
| EP-0761664-A1 | Camphor derivatives as new odorants | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1997-03-12 | — | — | EP | claimed |
| US-20080161223-A1 | Spirobornyl-2,4-(1,3-Dioxanes)] And Their Uses As Fragrance Ingredients | GIVAUDAN SA (CH) | 2008-07-03 | — | — | US | disclosed |
| US-20080161223-A1 | Spirobornyl-2,4-(1,3-Dioxanes)] And Their Uses As Fragrance Ingredients | GIVAUDAN SA (CH) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161223-A1 | Spirobornyl-2,4-(1,3-Dioxanes)] And Their Uses As Fragrance Ingredients | TRPA1, TRPV1, SRD5A1 | CHRM1 4473/4885CHRM2 4630/4885PLA2G1B 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.